Skip to content
Our Company
Our People
Plasma & IVIG
Primary Immunodeficiency Disease
Medical Affairs
Our Products
PRODUCT WEBSITES
PROCESS & CAPABILITIES
Press Releases
Financial Info
Company Info
Stock Info
Analyst Coverage
SEC Filings
Events & Webcasts
Governance
1.0-About-ADMA-Biologics.jpg

About ADMA Biologics

Leading the way with innovative immune globulin products

ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of manufacturing, marketing, and commercializing specialty biologic products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for certain infections. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.

With three FDA-approved products, including ASCENIV™ (Immune Globulin Intravenous, Human–slra), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (Hepatitis B Immune Globulin, Human), ADMA’s mission is to continue to successfully develop and commercialize specialty biologic products, targeted to specific patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.

Graphic showing vial containing antibodies

Leading the way with innovative immune globulin products

ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of manufacturing, marketing, and commercializing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for certain infections. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.

With three FDA-licensed approved products, including ASCENIV™ (Immune Globulin Intravenous, Human – slra), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (Hepatitis B Immune Globulin, Human), ADMA’s mission is to continue to successfully develop and commercialize plasma-derived, human immune globulins targeted to specific patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.

ADMA-Corp-Vial-Antibodies-RGB 1

Hear what drives us


We are dedicated to advancing a new age of specialty biologic products. Learn about the passion, values, and promise that drive ADMA Biologics.

ADMA Biologics is the only US-domiciled producer of plasma-derived therapeutics

  • Rapidly growing and diversified commercial product portfolio and contract development and manufacturing organization (CDMO) platform
  • Strong patent portfolio supports pipeline optionality and long-term growth opportunities
  • World class, cGMP-compliant biologics manufacturing plant with up to ~600,000 L annual plasma fractionation and purification capacity
  • End-to-end supply chain control, including fill-finish capabilities supporting internal production and external CDMO opportunities
  • Advancing toward raw material plasma supply self-sufficiency with 10 plasma collection centers under corporate umbrella
  • Three FDA-approved products: ASCENIV™ (Immune Globulin Intravenous, Human–slra), BIVIGAM® (Immune Globulin Intravenous, Human) and Nabi-HB® (Hepatitis B Immune Globulin, Human)
  • Thought leader in the development and commercialization of hyperimmune IG products
  • Consistent, reliable, and uninterrupted raw material supply

Through our relentless commitment to improving patients' lives, we are leading a new age with proven immunotechnology

Graphic of group of antibodies

Explore our patented immunotechnology

General_BAdge (1) 1
TMT-fast500-2022-logo-header-black 1-1
BioFlorida-1
BioFlorida-19-1
2014-NJBIZ-Logo 1-1